- Home
- PBYI vs HLLY Comparison
PBYI vs HLLY Comparison
Compare PBYI & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | HLLY |
|---|---|---|
| Founded | 2010 | 1903 |
| Country | United States | United States |
| Employees | N/A | 1483 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.9M | 395.5M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | HLLY |
|---|---|---|
| Price | $7.33 | $2.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 175.1K | ★ 813.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $1.98 |
| 52 Week High | $7.90 | $4.48 |
Technical Indicators
Market Signals| Indicator | PBYI | HLLY |
|---|---|---|
| Relative Strength Index (RSI) | 56.25 | 42.82 |
| Support Level | $7.09 | $2.46 |
| Resistance Level | $7.31 | $4.32 |
| Average True Range (ATR) | 0.25 | 0.13 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 78.08 | 16.52 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About HLLY Holley Inc.
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.